key: cord-0935700-pgr0q7st
authors: Patelli, Gianluigi; Paganoni, Silvia; Besana, Francesca; Codazzi, Fabiana; Ronzoni, Mattia; Manini, Simone; Remuzzi, Andrea
title: Preliminar detection of lung hypoperfusion in discharged Covid-19 patients during recovery
date: 2020-06-09
journal: Eur J Radiol
DOI: 10.1016/j.ejrad.2020.109121
sha: b2df46ff3d688952a82caacf1e01fdf8f6d9dac2
doc_id: 935700
cord_uid: pgr0q7st

nan

microcirculation [3, 4] . This important immune response attracts virus-specific T cells to the site of infection, where they can eliminate the infected cells. Alveolar macrophages can then recognize neutralized viruses and apoptotic cells and clear them by phagocytosis, resulting in recovery [5] . Despite these pathophysiological mechanisms are under continuous investigation, there are only a few reports on the clinical course during the recovery phase of the disease. Recent investigations [6, 7] show that lung abnormalities on chest computerized tomography (CT) show the greatest severity approximately 6-11 days after the initial onset of symptoms, while in the following weeks' recovery occurs consistently and in about 30 days lung tissue lesions are almost absorbed [8] . However, extended observation on COVID-19 patient during recovery are still object of investigation. More than 2,000 patients were admitted in our hospital (Bolognini Hospital, ASST Bergamo Est) during the COVID-19 outbreak, and we now starting to follow them during recovery. We reviewed CT findings in some of these patients in which CT scans were used to investigate potential thrombotic events with and without contrast media. We report here the preliminar results of these investigations in relation to lung perfusion conditions. We did identify perfusion defects in lungs of these patients, more than one month after remission of the symptoms, that deserve attention.

During the period from April 15 to 30, twenty patients (12 male and 8 female; age range 35-86, mean age 58+10) previously treated for pneumonia SARS-CoV-2, with negative swab, have been admitted to our department to assess the outcome of SARS-CoV-2 pneumonia. Chest CT was performed at an interval between 14 and 60 days after remission of the fever (average 40+13 days). Twelve patients reported an almost complete resolution of the symptoms, while 8 patients reported residual dyspnea. Of these 8 patients, 3 reported dyspnea with minimal motor activity, while in the others after prolonged effort. Control CT was performed in 5 patients with contrast media for suspected thromboembolism (including those with dyspnea with minimal motor activity, or patients with D-Dimer value over normal range). 90 HU) and venous phase acquisition (60 sec from the threshold). Images were viewed using IMPAX version 6.6.1 (Agfa-Gevaert NV Septestraat 27B-2640 Mortsel -Belgium). Every chest CT examination was evaluated by two double-blind experienced radiologists. The lung perfusion evaluation was performed by using PAA (Pulmonary Artery Analysis) Software [9] using Hounsfield Units (HU)-based colormap visualization tool (color palette ranging from -749 to -983 HU). The threshold level identified for normal lung tissue perfusion in control subjects was equal to -890 HU, with lower attenuation values considered as hypoperfusion.

We quantified the volume of low perfusion lung tissue, independently by the amount of contrast media, using the following method. The previously mentioned range of HU for hypoperfused threshold (HU < -890) in the control group was on average 13.3% of the total HU range air to contrast media in pulmonary artery. We then assumed this percentage, and calculated patient-specific threshold for hypoperfused tissue, on the basis of HU range from air to pulmonary artery. To estimate the percentage of lung volume characterized by hypoperfusion, we segmented the lung volume of the CT scans by automatic lung segmentation using the u-net (R231) convolutional network[10], a model trained on a large dataset including COVID-19 CT slices. Segmentation on individual slices allowed to extract the right and left lung mask separately, with the trachea not included in the lung segmentation. We labeled each pixel inside the lung mask as low perfusion or normal perfusion based on the patient-specific thresholds using Python implementation of SimpleITK library (https://simpleitk.org/about.html).

Out of the 20 patients who underwent follow-up, 12 patients had complete resolution of symptoms, with complete regression of the thickening areas detected with chest CT scan in 4 patients, and persistence of fibrous stripes areas in the other 8 patients. In the remaining patients, 5 reported dyspnea after prolonged effort, with 3 of them with complete remission of interstitial pneumonia and 2 with only partial remission. The 3 other patients reported dyspnea with minimal effort but showed a completely normal CT scan and remission of parenchymal opacity. These results indicate that persistent dyspnea is not associated with signs of interstitial pneumonia.

In the 5 patients studied with contrast media, 3 were those that reported dyspnea with minimal effort, while the other 2 had no such symptom. At CT evaluation, no signs of thromboembolism were present in all these patients. Of interest, in the 3 patients affected by dyspnea color map representation (see Fig. 1 ) showed diffuse hypoperfused areas (dark red/violet) not uniform between the left and right lung. Quantification of hypoperfused lung volume showed that, while in normal controls this volume was in average 8.5%, in these patients, that reported dyspnea, the volume ranged from 21.0% to 48.4% (Table 1) .

Of interest, tissue lung perfusion was normal in the two patients without dyspnea (see Table 1 and Figure   J o u r n a l P r e -p r o o f 1), with hypoperfused lung volume of 7.4% and 8.5%, respectively. Thus, the presence of dyspnea was associated with hypoperfused lung volume rather than with abnormal lung ventilation at CT.

cells, overproduction of pro-inflammatory cytokines and activation of complement and coagulation system in the microcirculation correlate with the initial appearance of areas of increased lung density with the "ground glass" appearance, which gradually tends to consolidate in areas preferentially located in the peripheral subpleural regions. Four stages of infection were recently proposed: early, progression, peak, and resolution [11] , and in the later stage of the infection, the pattern referred to as "crazy paving" and "reversed halo sign" have been found more frequently [11] . Little is known, however, on the recovery phase of the disease. Our preliminar retrospective analysis, based on volumetric image processing, show that in symptomatic patients (dyspnea) one moths after remission from fever, despite the absence of pulmonary fibrous stripes residues, extended hypoperfused areas of lung parenchyma are still present. These findings suggest that during the recovery of COVID-19 important defects in lung blood perfusion of the microcirculation may persist even with normal lung CT.

To our knowledge, this is the first report on quantitative estimation of lung microvasculature defect, without thromboembolism, in COVID-19 patients due incomplete healing of alveolar parenchyma microcirculation that persist during recovery. Thus, while the lung tissue damage related to interstitial fluid accumulation and impairment of ventilation is almost completely recovered within one month, a persistent defect of the microcirculation may remain, likely due to residual of viral-induced inflammation, with immune cell accumulation, platelet adhesion and micro-disseminated thrombi. Whether also fibrosis may be responsible for these microcirculation perfusion defects is worth to investigate. While these complications of the disease are now well recognized during the acute phase of the infection[12, 13, 14] , it is important to notice that this impairment of the microcirculation, we have detected, may affect lung function even in the recovery phase and may last for a long time or even not be healed with time. This evidence should be carefully considered, due to the potential clinical relevance of the problem in the large actual number of patients affected by the SARS-CoV-2 infection worldwide.

In summary, the main message from our observation is that in discharged COVID-19 patients still reporting dyspnea, chest CT should be used to quantify the presence of lung perfusion dysfunction. This is important not only for diagnosis, but also to determine the incidence of these complications, whether this damage to the lung microcirculation will resolve with time and the need for specific pharmacological interventions. The second message is that it is important to follow COVID-19 patients during recovery to estimate the. Deeper knowledge of these pathological processes it is very important for this increasing in J o u r n a l P r e -p r o o f 

COVID-2019) situation reports. Situation report-114

The trinity of COVID-19: immunity, inflammation and intervention

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

SARS-CoV-2 and viral sepsis: observations and hypotheses

Serial CT features in discharged COVID-19 patients with positive RT-PCR re-test

Artificial intelligence to codify lung CT in Covid-19 patients

Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study

Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia

Improved Accuracy of Pulmonary Embolism Computer-Aided Detection Using Iterative Reconstruction Compared With Filtered Back Projection

Hyperinflammation and derangement of reninangiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis

Pulmonary embolism in COVID-19: Ventilation and perfusion computed tomography